Madagascar vs Venezuela: Immunization, Hib3 (% of children ages 12-23 months)
Madagascar
60.0%
in 2024
Venezuela
62.0%
in 2024
Madagascar rank
182nd
Venezuela rank
180th
Immunization, Hib3 (% of children ages 12-23 months) over time
- Madagascar
- Venezuela
How they compare
Venezuela currently reports 62.0% against 60.0% in Madagascar, a difference of 2.0%.
The two have swapped places 5 times across 17 shared years of data; in 2008 it was Madagascar ahead.
Madagascar ranks 182nd and Venezuela ranks 180th of 191 countries.
Across the 3 decades both report, Madagascar averaged higher in 1 and Venezuela in 2.
Head to head by decade
| Decade | Madagascar | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 64.5% | 67.5% | 3.0% | Venezuela |
| 2010s | 68.8% | 75.8% | 7.0% | Venezuela |
| 2020s | 60.8% | 53.8% | 7.0% | Madagascar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Madagascar or Venezuela?
- Venezuela, at 62.0% against 60.0% in Madagascar as of 2024.
- What is the difference in immunization, hib3 between Madagascar and Venezuela?
- 2.0%, with Venezuela ahead.
- How many years of comparable data are there for Madagascar and Venezuela?
- 17 years are reported by both, from 2008 to 2024.
- How do Madagascar and Venezuela rank globally for immunization, hib3?
- Madagascar ranks 182nd and Venezuela ranks 180th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.